Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

IP and the Generics Industry

8th July 2015, London, United Kingdom

Overview of the Masterclass

Open/Close

Intellectual Property lies at the very heart of the generics and biosimilars industry and it is vital to understand why the subject is so important. It represents the front line in the battles between originators, who want to protect their inventions for as long as possible, and the generic firms that want to copy their products as soon as possible.
A good understanding of the topic is vital for anyone working in either originator or generic companies as, without it, there is a risk of making very expensive mistakes.
 

Why you should attend

Open/Close

About the Masterclass Leader

Open/Close

About the Organisation

Open/Close